Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246608 · ClinicalTrials.gov registry record · NA
Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy
A NA study of Open Wound Abdominal Wall and Wound Non Healing, sponsored by Kettering Health Network.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT02246608: Completed NA study of Open Wound Abdominal Wall and Wound Non Healing, sponsored by Kettering Health Network.
NCT02246608 is a NA study of Open Wound Abdominal Wall and Wound Non Healing that has completed, run by Kettering Health Network. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246608, a NA study of Open Wound Abdominal Wall and Wound Non Healing, has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the therapeutic effect of Oasis® Matrix along with Negative Pressure Wound Therapy (NPWT) on pressure wounds. Either Oasis or standard foam will be applied to the wound prior to activating the NPWT.
Conditions Studied
Interventions
- DEVICE NPWT Standard of Care plus Oasis wound product
- DEVICE Routine NPWT Standard of Care
Study Locations (1)
Ohio
- Kettering Medical Center - Kettering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02246608
The ClinicalTrials.gov registry entry for NCT02246608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kettering Health Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Open Wound Abdominal Wall appearing as the primary indexed condition, and to 2 interventions - of which NPWT Standard of Care plus Oasis wound product is the first listed.
NCT02246608 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02246608 about?
NCT02246608 is a clinical study titled "Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy". This study evaluates the therapeutic effect of Oasis® Matrix along with Negative Pressure Wound Therapy (NPWT) on pressure wounds. Either Oasis or standard foam will be applied to the wound prior to activating the NPWT.
What is the current status of trial NCT02246608?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-08. Estimated completion is 2018-01.
What conditions does trial NCT02246608 study?
This clinical trial studies the following conditions: Open Wound Abdominal Wall, Wound Non Healing.
What interventions are being tested in trial NCT02246608?
The interventions under investigation include: NPWT Standard of Care plus Oasis wound product (DEVICE), Routine NPWT Standard of Care (DEVICE).
Who is sponsoring clinical trial NCT02246608?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02246608 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.